Michael Lee Brooks - 16 Dec 2021 Form 4 Insider Report for Syneos Health, Inc.

Role
Chief Development Officer, Clinical Solutions
Signature
/s/ Sara Epstein, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
16 Dec 2021
Net transactions value
-$59,637
Form type
4
Filing time
20 Dec 2021, 16:10:23 UTC
Previous filing
05 Nov 2021
Next filing
23 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYNH Class A Common Stock Tax liability $59,637 -603 -6.3% $98.90 8,924 16 Dec 2021 By spouse
holding SYNH Class A Common Stock 32,999 16 Dec 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Chief Development Officer, Clinical Solutions